- Home
- MGYR vs PROK Comparison
MGYR vs PROK Comparison
Compare MGYR & PROK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGYR
- PROK
- Stock Information
- Founded
- MGYR 1922
- PROK 2015
- Country
- MGYR United States
- PROK United States
- Employees
- MGYR N/A
- PROK N/A
- Industry
- MGYR Savings Institutions
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MGYR Finance
- PROK Health Care
- Exchange
- MGYR Nasdaq
- PROK Nasdaq
- Market Cap
- MGYR 88.8M
- PROK 94.9M
- IPO Year
- MGYR 2006
- PROK N/A
- Fundamental
- Price
- MGYR $14.70
- PROK $0.72
- Analyst Decision
- MGYR
- PROK Buy
- Analyst Count
- MGYR 0
- PROK 4
- Target Price
- MGYR N/A
- PROK $5.00
- AVG Volume (30 Days)
- MGYR 2.4K
- PROK 1.1M
- Earning Date
- MGYR 04-30-2025
- PROK 05-16-2025
- Dividend Yield
- MGYR 1.77%
- PROK N/A
- EPS Growth
- MGYR 19.36
- PROK N/A
- EPS
- MGYR 1.43
- PROK N/A
- Revenue
- MGYR $34,067,000.00
- PROK $76,000.00
- Revenue This Year
- MGYR N/A
- PROK N/A
- Revenue Next Year
- MGYR N/A
- PROK N/A
- P/E Ratio
- MGYR $10.30
- PROK N/A
- Revenue Growth
- MGYR 12.12
- PROK N/A
- 52 Week Low
- MGYR $10.66
- PROK $0.46
- 52 Week High
- MGYR $14.90
- PROK $4.44
- Technical
- Relative Strength Index (RSI)
- MGYR 62.53
- PROK 42.92
- Support Level
- MGYR $14.35
- PROK $0.94
- Resistance Level
- MGYR $14.72
- PROK $0.77
- Average True Range (ATR)
- MGYR 0.24
- PROK 0.12
- MACD
- MGYR 0.10
- PROK -0.01
- Stochastic Oscillator
- MGYR 97.94
- PROK 21.71
About MGYR Magyar Bancorp Inc.
Magyar Bancorp Inc is a mid-tier stock holding company. The Company offers a full array of commercial and retail financial services, including the taking of time, savings and demand deposits; the making of commercial, consumer and home equity loans; and the provision of other financial services. The business consists of getting retail deposits from the general public in the areas surrounding the main office in New Brunswick, New Jersey and branch offices located in Middlesex and Somerset Counties, New Jersey, and investing those deposits, together with funds generated from operations and wholesale funding, in residential mortgage loans, home equity loans, home equity lines of credit, commercial real estate loans, commercial business loans, Small Business Administration loans.
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's cells isolated from the patient intended for treatment. Its product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of the development program for severe diabetic kidney disease.